rVSV-ZEBOV-GP

vesicular stomatitis virus-based Ebola vaccine (GP) · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rVSV-ZEBOV-GP, covering 2018-10-12 to 2018-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) [Phase 3]

See pricing